ArticleCardiology2025

Long-Term Administration of Multikinase Inhibitors Is a Potential Risk Factor for Atherosclerosis in Patients with Thyroid Cancer.

Nao Muraoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.